Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)
NCT ID: NCT01148212
Last Updated: 2011-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2009-06-30
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
saline-soaked sponges electrode with electrode gel tap-water-soaked sponges tap-water-soaked-sponges + sham stimulation
Outcome measures are tolerability (comfort rating questionnaire), impedances, skin elasticity
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis
NCT02085421
Anodal tDCS in Chronic Migraine With Medication Overuse
NCT04336267
Transcranial Direct Current Stimulation in a Home Treatment Setting for Major Depression
NCT05172505
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
NCT06009523
The Effect of tDCS on Motor Performance and Cortical Excitability
NCT01740843
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
Exclusion Criteria
* medication with corticoids
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ludwig-Maximilian-University Munich
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulrich Palm, MD
Role: PRINCIPAL_INVESTIGATOR
Ludwig-Maximilian-University
Frank Padberg, MD
Role: STUDY_CHAIR
Ludwig-Maximilian-University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ludwig-Maximilian-University, Dept. of Psychiatry
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.